Search

everythinglearnresearchcommunity

for

Search:↓

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Neurosteroids show promise for treating epilepsy and more research is needed.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The β-sitosterol hair gel is effective and promising for treating hair loss.

Plant extracts in shampoo improved hair thickness and density in men with hair loss.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Stress hormones like cortisol may trigger psoriasis flare-ups.

Editing the FGF5 gene in sheep increases fine wool growth.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.